Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Pills leaning against coinsThe order is a first step that instructs the U.S. Department of Health and Human Services to begin the rule-making process to test “a payment model” for some medicines. (Bloomberg) –President Donald Trump started a process that could cut some U.S. drug costs by tying prices to those paid by countries with national health systems, a move drugmakers said will stifle innovation.

The order, released on Sunday, came after an earlier attempt to force pharmaceutical companies to make reductions didn’t yield results.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.